Key result
Balloon pulmonary angioplasty significantly reduced mean pulmonary artery pressure by 2.53 mmHg and rapidly improved right ventricular structural parameters within 24 hours, with the greatest benefits observed in patients with moderate to severe pulmonary hypertension.
Why the study?
To analyze right heart structure and function improvements after BPA in CTEPH patients with different degrees of pulmonary hypertension to assess efficacy and help guide treatment strategies.
Does balloon pulmonary angioplasty improve right ventricular structure and hemodynamics in patients with chronic thromboembolic pulmonary hypertension?
Observational (n=94)
No
Does balloon pulmonary angioplasty improve right ventricular structure and hemodynamics in patients with chronic thromboembolic pulmonary hypertension?
Mean Difference: 2.53 (95% CI 1.39–3.67)
Absolute Event Rate: 37.55% vs 40.07%
p-value: p=<0.001
May support acute BPA use in CTEPH; hypothesis-generating and leaves open need for RCTs.
Objective: Analyze the improvement of right heart structure and function in CTEPH patients with different degrees of pulmonary hypertension after BPA treatment, in order to provide a basis for determining the effectiveness of BPA treatment, and to screen patients with different treatment effects and adjust the subsequent treatment strategies. Method: The patients with CTEPH were selected for preoperative echocardiography, and the right ventricular systolic function parameters, pulmonary artery pressure parameters, left ventricular related parameters were measured; RHC were measured before and after BPA. Perform another echocardiographic within 24 hours after BPA. According to the results of RHC-mPAP before BPA, CTEPH patients were divided into three groups: mild pH, moderate pH and severe PH. Compare the changes in pulmonary artery pressure, right heart structure, and function among three groups of patients after BPA, and analyze their treatment effects. Results: A total of 94 CTEPH patients were included in the study, including 30 mild PH patients, 37 moderate PH patients, and 27 severe PH patients. After BPA, TPVR was significantly reduced in all patients (P=0.029, P=0.002, P=0.004). RHC-sPAP, RHC-mPAP and PVR were decreased in patients with moderate PH (P=0.004, P=0.005, P=0.002) and severe PH (P<0.001, P=0.001, P=0.003); The PAD, RAEDA, RAESA, RVEDA, RVESA, IVCmax, IVCmin and CRIVC in patients with moderate PH were significantly improved. TRA and ∆PTR were also reduced (P<0.001, P=0.001); RAEDA, RAESA, RVEDA, RVESA, FAC, IVCmax, IVCmin were also significantly improved in patients with severe PH. However, patients with mild PH showed no significant changes in the RV volume and hemodynamic parameters. In all patients, RV systolic function parameters (TAPSE, S’, RIMP, RVFAC) did not improve significantly after BPA within 24 hours. Conclusion: BPA has an ideal and rapid therapeutic effect on CTEPH patients with moderate/severe PH, and the therapeutic effect of moderate PH is better than that of severe PH, but not in mild PH; Rapid assessment of patient response after BPA could help screen patients with poor treatment outcomes to consider adjustment for subsequent treatment decisions. After BPA, the structural inverse remodeling of the right heart appeared earlier than the functional inverse remodeling.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2023) conducted an observational in Chronic thromboembolic pulmonary hypertension (CTEPH) (n=94). Balloon pulmonary angioplasty (BPA) vs. Pre-procedure baseline was evaluated on Mean pulmonary artery pressure (mPAP) (MD 2.53 mmHg reduction, 95% CI 1.39-3.67, p=<0.001). Balloon pulmonary angioplasty significantly reduced mean pulmonary artery pressure by 2.53 mmHg and rapidly improved right ventricular structural parameters within 24 hours, with the greatest benefits observed in patients with moderate to severe pulmonary hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: